CORNEAL CONSULTANTS OF COLORADO, P.C.

Our PracticeServicesPublicactionsMap & DirectionsContact Us
Return HomeRichard E. Damiano, M.D. and S. Lance Forstot, M.D. 303.730.0404
WHAT IS A CORNEAL TRANSPLANT?
THE CORNEA, THE CLEAR TRANSPARENT TISSUE COVERING OVER THE IRIS CAN BE
affected by many different disorders, significantly diminishing vision. When the clarity of the cornea becomes opaque to the degree of causing vision loss or is severely impacted by disease, a corneal transplant (known as a keratoplasty) may be necessary to restore vision.
A corneal transplant is the replacement of a damaged or diseased cornea (host cornea) by a donor cornea. Like organ transplants, the donor corneal tissue comes from a special bank, which receives donor tissue to save lives, and in this case, preserve vision. Unlike other transplants, the corneal graft does not need to go through extensive typing procedure in order to match donor and host. Donor corneal tissue is selected by factors such as the donor's age, cause of death, duration between the death and transplant, and the presence of donor eye disease, such as AIDS, syphilis or hepatitis, or previous eye surgery.
In this procedure, a surgeon carefully removes the central cornea tissue that is damaged or diseased with an instrument called a trephine and replaces it with a precisely matched donor corneal graft. The donor graft is anchored to the surrounding host tissue by tiny hair-thin sutures. The surgery is performed with general or local anesthetic on an outpatient basis for most cases.
> Return to top
REASONS FOR RECEIVING A CORNEAL TRANSPLANT
Corneal transplants are performed for the following reasons:
Optical treatment
To improve optical quality and enhance vision. Examples of conditions
requiring optical treatment are replacing an opaque, scarred cornea or a
cornea distorted by severe astigmatism due to keratoconus.
Reconstructive treatment
To reconstruct the anatomy of the cornea and preserve the eye, as in
such cases where the cornea is perforated.
Therapeutic treatment
To preserve the eye by treating diseases that are unresponsive to
medications or other forms of medical therapy. As example, therapeutic
management may involve treating recurrent ruptured bullae in bullous
keratopathy or a severe, uncontrolled fungal corneal ulcer.
Common conditions for corneal transplantation are bullous keratopathy (as in diseases such as Fuch's dystrophy that cause endothelium cell loss), keratoconus, keratitis (viral, bacterial or fungal inflammation of the cornea causing perforation), corneal stromal dystrophies (degradation of the middle layer or stroma of the cornea) and regrafts.
> Return to top
RECOVERY
The recovery period after a corneal transplant is long in that it takes adjustment time for vision to gradually return. After surgery, to prevent the eye from possible trauma (bumping, hitting or rubbing the cornea), shields are worn. Topical antibiotics are used for several weeks and topical corticosteroids for several months to reduce the possibility of infection or graft rejection. Strenuous activity such as lifting, bending or straining should be avoided for several weeks.
Early in the postoperative stage, the surgeon can monitor the cornea shape through corneal topography, a computer mapping of the cornea, to control astigmatism (caused by sutures changing the cornea shape). By adjusting sutures or selectively removing sutures, the cornea shape can be controlled to avoid or reduce astigmatism. In some cases, patients may wear a rigid, hard contact lens over the corneal transplant to reduce astigmatism. Achieving full vision function can occur after surgery from six months to a year depending upon wound healing time, changing refraction and corneal astigmatism.
> Return to top
COMPLICATIONS
Corneal transplant complications include possible infection (intraocular and corneal), graft rejection or failure, intraocular bleeding, glaucoma, high refractive error (astigmatism or myopia) and recurrence of disease, such as corneal stroma dystrophy. Medications such as antibiotics and corticosteroids, or careful monitoring with treatment adjustment can reduce or prevent complications such as these.
Graft rejection is not uncommon. Symptoms such as photosensitivity, ocular ache or redness, and decreased vision can be an indication of rejection. Treatment with corticosteroids, ocular injections or occaisionally IV, may be used to reverse graft rejection. The graft may fail if the graft rejection is severe, endures for a long period of time or has multiple occurrences of rejection. Regraft is a possible solution. However, long-term prognosis for a regraft is lower than it was for the original graft.
> Return to top
PROGNOSIS
The success rate of corneal transplant surgery varies according to your diagnosis and factors such as glaucoma, retinal degeneration or optic nerve disease, which may affect final vision. On average the long-term transplant success rate is about 85%-90% for conditions such as keratoconus, corneal scars, early bullous keratopathy, corneal stromal dystrophies or inactive viral keratitis. Active corneal infections and chemical or radiation injuries are much more difficult to treat for full vision restoration due to progressive inflammation or damage to other portions of the eye. Your ophthalmologist will consult with you about your specific condition and can assess more accurately your long-term prognosis based on the specific factors affecting your individual case.
> Return to top

Our Practice l Services l Publications l Map & Directions l Contact Us l Privacy Policy
Cataracts l Cornea and External Diseases l Corneal Transplants l Refractive Errors
Refractive Surgery l Optics

All contents © copyright 2002-2004 Corneal Consultants of Colorado, P.C. All rights reserved.
Development by Mindshare HDV.
The basic reason for a
transplant is loss of vision
due to corneal
opacification-- the inability
to see through a diseased
or damaged cornea.
One of the risks of any
transplant is the possibility
of rejection. The body's
defense system tries to
destroy things that are not
natural parts of itself, as
such, it will attack the
foreign corneal graft and
may cause inflammation.
Signs of rejection are
loss of clarity and swelling.
Often, corneal transplant
rejection can be stopped
with medication.